A Study To Assess GW433908 (Fosamprenavir) Containing Regimens In HIV-1 Infected Subjects

Completed · Phase 3

Conditions studied: Infection, Human Immunodeficiency Virus

In brief

GW433908 (fosamprenavir; FPV)is a pro-drug of amprenavir (APV) which is more water soluble and can be formulated into a tablet with a reduced pill burden (four 700mg tablets of FPV versus sixteen 150mg capsules daily for APV. This study is designed to provide additional information on long term safety and tolerability of FPV containing regimens for those subjects who received FPV in previous GlaxoSmithKline studies.

Key facts

Study ID

NCT00296504

Run by

ViiV Healthcare

People needed

753

Starts

2001-11-01

Expected to finish

2010-10-01

Last updated by the study team

2013-04-19

Who can join

Age: 13 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Male or non-pregnant/non-lactating females >/=13 years of age (or >/= 18 years of age according to local requirements).
• Received fosamprenavir through prior participation in APV20001, APV30002, APV30003 or PRO30017 or have participated in APV30001 or other studies as deemed appropriate by the project team.

You may not qualify if…

• Permanent discontinuation of GW433908 in a previous study due to intolerance.
• An active CDC Class C Event.
• Any condition which, in the opinion of the investigator, would preclude a subject from participation.

Where it is running

• GSK Investigational Site — Fountain Valley, California, United States
• GSK Investigational Site — San Francisco, California, United States
• GSK Investigational Site — Denver, Colorado, United States
• GSK Investigational Site — Fort Lauderdale, Florida, United States
• GSK Investigational Site — Orlando, Florida, United States
• GSK Investigational Site — Orlando, Florida, United States
• GSK Investigational Site — Sarasota, Florida, United States
• GSK Investigational Site — Tampa, Florida, United States
• GSK Investigational Site — Manhasset, New York, United States
• GSK Investigational Site — Galveston, Texas, United States
• GSK Investigational Site — Campinas, São Paulo, Brazil
• GSK Investigational Site — Santiago, Región Metro de Santiago, Chile
• GSK Investigational Site — Le Kremlin-Bicêtre, France
• GSK Investigational Site — Marseille, France
• GSK Investigational Site — Paris, France
• GSK Investigational Site — Paris, France
• GSK Investigational Site — Vandœuvre-lès-Nancy, France
• GSK Investigational Site — Villejuif, France
• GSK Investigational Site — Genoa, Liguria, Italy
• GSK Investigational Site — Coimbra, Portugal
• GSK Investigational Site — Badajoz, Spain
• GSK Investigational Site — Barcelona, Spain
• GSK Investigational Site — London, United Kingdom
• GSK Investigational Site — London, United Kingdom

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.